Urticaria Centers of Reference and Excellence (UCARE) 2023 | São Paulo

Exploring the role of type 2 inflammation and the neuroimmune axis in CSU, and how emerging therapeutics are targeting key molecules in these pathways.

Marcus Maurer +3 more

See post-event materials

Past event

8December2023

Location

Rebouças Convention Center, Grande Auditório

São Paulo Brazil

Learning objectives

Enhance awareness of emerging clinical trial data in CSU
Learn about the role of type 2 inflammation in the pathogenesis of CSU
Explore the role of the neuroimmune axis in CSU

Description

Targeting Type 2 Inflammation in CSU – Clinical and Mechanistic Implications

Symposium focusing on the key roles of type 2 inflammation and the neuroimmune axis in CSU pathophysiology. Current understanding of these pathways has guided development of emerging therapeutics that target molecular drivers within type 2 inflammation, from which Phase 3 efficacy and safety data are presented and explored. Dr. Ensina guides discussions on the perspective of CSU management in Brazil. Dr. Maurer explores current clinical data from leading emerging therapies in CSU. Drs. Saini and Kim provide a deep dive into the pathophysiology of type 2 inflammation and the neuroimmune axis in CSU.

Agenda:

Welcome & Introduction, Marcus Maurer (Chair)
CSU – The Brazil Perspective, Luis Felipe Ensina
Emerging Clinical Trial Data in CSU, Marcus Maurer
Role of Type 2 Inflammation in CSU Pathogenesis, Sarbjit Saini
Neuronal Involvement in CSU, Brian Kim
Panel Discussion/Q&A, All faculty

MAT-GLB-2303901 V1 12/2023

Location

Rebouças Convention Center, Grande Auditório

São Paulo Brazil

Speakers

Dermatology

Marcus Maurer

Professor of Dermatology and Allergy; Head of Dermatological Allergology; Director of Research at the Department of Dermatology and Allergy and the Allergie-Centrum-Charité, Charité – Universitätsmedizin, Berlin, Germany

Dermatology

Brian Kim

Professor, Vice Chair of Research, and Site Chair of Mount Sinai West, Icahn School of Medicine, NY, US

Allergy/Immunology

MD, PhD

Luis Felipe Ensina

Professor of Immunology, Federal University of São Paulo, Brazil

Allergy/Immunology

Sarbjit Saini

Professor of Medicine, Johns Hopkins University School of Medicine in Baltimore, Maryland, United States

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: PeruChange country/region

Dermatology

Urticaria Centers of Reference and Excellence (UCARE) 2023 | São Paulo

Exploring the role of type 2 inflammation and the neuroimmune axis in CSU, and how emerging therapeutics are targeting key molecules in these pathways.

Marcus Maurer +3 more

See post-event materials

Past event

8December2023

Location

Rebouças Convention Center, Grande Auditório

São Paulo Brazil